Kantoff Philip W. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Kantoff Philip W. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Philip W. Kantoff is listed in SEC filings as a Director of Context Therapeutics Inc. as of June 26, 2026. In the broader public record, Dr. Kantoff is a prominent physician-scientist and professor of medicine at Harvard Medical School with a long-standing focus on oncology and cancer therapeutics, including prostate cancer research. He has also served in leadership and advisory roles within the biotechnology sector.

Board memberships

• Context Therapeutics Inc.

Awards & honors

• Director, Context Therapeutics Inc. (as of 2026-06-26)
• Renowned physician-scientist and professor of medicine at Harvard Medical School
• Extensive contributions to oncology and translational cancer research

Companies — Last 90 Days

• Context Therapeutics Inc. (CNTX) — 1 filings, last 2026-06-26

Frequently Asked Questions

Who is Kantoff Philip W.?

Philip W. Kantoff is listed in SEC filings as a Director of Context Therapeutics Inc. as of June 26, 2026. In the broader public record, Dr. Kantoff is a prominent physician-scientist and professor of medicine at Harvard Medical School with a long-standing focus on oncology and cancer therapeutics, including prostate cancer research. He has also served in leadership and advisor…

How many SEC Form 4 filings has Kantoff Philip W. submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Kantoff Philip W.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week